Use of Calcineurin Inhibitors in
Atopic Eczema :EuroGuiDerm Guideline 2022
Effective topical therapy depends on three fundamental principles: sufficient potency, sufficient dosage and correct application. Current approved topical anti-inflammatory therapies are corticosteroids (TCS), calcineurin inhibitors (TCI) and a phosphodiesterase 4 (PDE-4) inhibitor. The latter is approved in the European Union but not yet available.
Modern Medicine – Issue 5 2022
